Clinical trials: CAEBV, open to volunteers
CAEBV (Chronic Active Epstein-Barr Virus Infection) Syndrome, PTLDs
Clinical Study of Therapeutic Immunological Agent for EBV Lymphoproliferative Diseases
This study intends to conduct a prospective single-center open single-arm multi-dose escalation study on therapeutic immunological agent treatment in patients with Lymphoproliferative disease associated with EBV to observe the…
- Trial name
- NCT06666153
- Testing
- EBV immunological agent
- Where
- China
- Volunteers
- 27 people
- Sponsor
- West China Hospital
Lymphohistiocytosis, EBV
Golidocitinib Combined With Selinexor for CAEBVD
This study is a multicenter, prospective, single-arm clinical investigation, with patients with CAEBVD as the main research subjects, to evaluate the effectiveness of the combined treatment regimen of golidocitinib and selinexor.
- Conditions
- Lymphohistiocytosis, EBV, CAEBV
- Trial name
- NCT07369739
- Testing
- golidocitinib, Selinexor (combination therapy)
- Where
- China
- Volunteers
- 28 people
- Sponsor
- Beijing Friendship Hospital
Chronic Active Epstein-Barr Virus
Genetic Studies of Chronic Active Epstein-Barr Disease
Epstein-Barr virus (EBV) is a member of the human herpes virus family that infects more than 95 percent of the U.S. population. Most infections occur in childhood and cause no symptoms; in adolescents and adults, EBV often causes…
- Trial name
- NCT00032513
- Where
- United States
- Volunteers
- 300 people
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)